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Administrative Core

Arthrospira/Limnospira oral Supplement for Enhancing Host Resilience to Virus Infection
Established in 2020 (www.umbdsrc.org)

The University of Mississippi Botanical Dietary Supplements Research Center (UM BDSRC) is a component of the NIH Consortium for Advancing Research on Botanicals
and other Natural Products (CARBON) Program. It was created to foster collaborations between scientists at the University of Mississippi housed at the main campus in
Oxford and the Medical Center in Jackson.

Public health relevance and significance

Arthrospira/Limnospira (commonly known as spirulina) is a top selling botanical for improving immune health. This center’s research is directed towards generating
sufficient data to optimally design future human intervention studies to evaluate the utility of Limnospira-derived oral supplements in promoting resilience against
and/or recovery from respiratory viral infections such as influenza. The use of a Limnospira-derived oral supplement may provide an important complementary
approach to currently available antiviral therapies that is inexpensive, safe and readily available to the public.
Influenza virus infection is a continual, worldwide public health problem that has challenged western society for centuries. The CDC estimates that the burden of illness
during the 2017–2018 flu season included 48.8 million symptomatically infected people in the U.S., 959,000 patient hospitalizations, and 79,400 deaths. Since the
modern flu vaccine program has moderated but not eliminated infection risk, enhancement of host antiviral immune response through the use of botanicals may
provide an important complementary approach.

What is the rationale for selecting Limnospira as the botanical product for our research?

Limnospira is a cyanobacterium that has been used as a food for centuries and more recently as a health supplement by a large segment of global society. Although
early interest in commercial production of Limnospira was focused mainly on its nutrient and protein content, it has emerged as a popular dietary supplement due to
scientific evidence supporting various human health benefits such as immune-enhancing and antiviral properties.
About 25 years ago the UM National Center for Natural Products Research (NCNPR) established a unit to investigate the immune-enhancing properties of botanicals and
dietary supplements. Numerous products that are traditionally used to enhance immune function were evaluated, and extracts from Limnospira were found to be
hundreds of times more active than all others tested. Based on this discovery, the NCNPR invested substantial research effort to investigate the immune-enhancing
properties and therapeutic applications of Limnospira.
A growing body of evidence generated from the NCNPR and the literature indicate that oral consumption of Limnospira products are particularly useful natural products
for providing resilience against influenza viral infection. Research demonstrates that a major mechanism by which Limnospira products provide anti-viral resilience is
through its impact on immune function. Through this research effort Braun-type lipoproteins were identified as the predominant macrophage-activating principal within
Limnospira, and a patented extract (ImmulinaTM) was developed that preferentially enriches for the level of these active macromolecules from the raw material. The
Immulina extract has been commercially available for the last 15 years and is the product research focus for our UM BDSRC.
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The objective is to advance research on the identification of chemical
marker(s) to monitor subject adherence (the extent to which they consume
the Immulina product). To identify adherence/surrogate marker candidates,
the Botanical Core team will implement hyphenated chromatographic
methods (viz., GC- or LC coupled withQToF-MS) to evaluate biological fluids
from human volunteers (collected before and after Immulina consumption)
for differential levels of compounds using both targeted and non-targeted
approaches.
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The overall purpose of the Botanical Core is to ensure product integrity and advance the chemistry research on the Limnospira-based product,
Immulina, by using a combination of bioassay- and chemical-based approaches.
Aim 1.
Ensure the unambiguous identification and perform additional safety testing on Limnospira fusiformis raw material that will be used in the
production of sufficient quantities of Immulina for the proposed research projects.
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Aim 2.
Validate a selective in vitro bioassay for quantitation of the toll-like receptor 2-dependent activity exhibited by the Braun-type lipoproteins in
Immulina extracts.
Aim 3.
Advance the chemistry research on Immulina by establishing chemical-based authentication and standardization approaches, characterization of
immune-inhibitory substances, and detailed structural analysis of the active immune-enhancing Braun-type lipoproteins.
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Project 1

Aim 4.
Perform additional stability studies, provide sufficient quantities of well-characterized and safe Immulina for use in the proposed UM BDSRC
research projects, and explore collaborative opportunities with other CARBON units.
Unraveling Immune Enhancement by Immulina
Aim 1.
Develop an optimized liquid formulation for Immulina.
Aim 2.
Evaluate the pharmacodynamics of Immulina and identify in vivo biomarker(s).
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Aim 3.
Investigate the molecular mechanism on immune enhancement by Immulina.
Statement of Potential Impact
The successful completion of this project will result in the development of an improved formulation of Immulina and the identification of in
vivo biomarkers for Immulina treatment.
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Project 2

Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections
Mouse model (Years 1-2)
Aim 1. Evaluate oral administration of Immulina in three non-lethal mouse models of resilience against influenza A virus infection (prophylaxis,
prodrome and recovery) to determine the most effective utility of Immulina for enhancing host immunity to improve antiviral resilience.
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Aim 2. Confirm that activation of the TLR2 signaling pathway by Braun-type lipoproteins is a causal mechanism through which Immulina enhances
host immunity against antiviral infection.
Human model (Years 3-5)
Aim 3. Determine the optimal form and dosage of the Immulina-based supplement that will maximize effects on increasing lymphocyte cell
numbers and/or activity, increased supporting cytokines, ADCC against influenza-infected target cell lines and influenza-specific antibody titers.
Aim 4. Establish the timeline for optimal lymphocyte, cytokine and antibody responses in terms of both initial changes and maximal changes and
duration of the change once the Immulina is discontinued in normal and immune compromised (elderly) human research participants.
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Aim 5. Examine the effects of routine influenzas vaccine given before, during, or after Immulina use to investigate influenza antigen-specific
antibody responses in individuals receiving Immulina supplement vs placebo.

